Development and validation of uplc method for the determination of olopatadine hydrochloride in polymeric nanoparticles
ACTA Pharmaceutica Sciencia · 2019
DOI: 10.23893/1307-2080.aps.05701 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACTA Pharmaceutica Sciencia, 2019. Verfasst von Umay Merve Güven und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
The conventional eye drops are the most convenient and patient compliant non-invasive route for topical ophthalmic drug delivery. Nasolachrymal drainage, epithelial membrane barriers and non-productive absorption of these ophthalmic preparations can result in poor ocular bioavailability and systemic absorption leading side effects. The limited duration time requires frequently dosing up to 4 times per day for many treatments 1. The active ingredient can ABSTRACT
Zitieren
APA
Güven, U. M., Berkman, M. S., & Yazan, Y. (2019). Development and validation of uplc method for the determination of olopatadine hydrochloride in polymeric nanoparticles. ACTA Pharmaceutica Sciencia. https://doi.org/10.23893/1307-2080.aps.05701
Vancouver
Güven UM, Berkman MS, Yazan Y. Development and validation of uplc method for the determination of olopatadine hydrochloride in polymeric nanoparticles. ACTA Pharmaceutica Sciencia. 2019. doi:10.23893/1307-2080.aps.05701
BibTeX
@article{Gven2019,
author = {Güven, Umay Merve and Berkman, Murat Sami and Yazan, Yasemin},
title = {Development and validation of uplc method for the determination of olopatadine hydrochloride in polymeric nanoparticles},
journal = {ACTA Pharmaceutica Sciencia},
year = {2019},
doi = {10.23893/1307-2080.aps.05701}
}
EUVIMED